How have SCYB shares performed in 2024?

Scythian Biosciences' stock was trading at C$3.49 at the start of the year. Since then, SCYB stock has increased by 0.0% and is now trading at C$3.49. View the best growth stocks for 2024 here .

What other stocks do shareholders of Scythian Biosciences own?

Based on aggregate information from My MarketBeat watchlists, some companies that other Scythian Biosciences investors own include Cross Timbers Royalty Trust (CRT) , Archer-Daniels-Midland (ADM) , InfraCap MLP ETF (AMZA) , Alliance Resource Partners (ARLP) , Brigham Minerals (MNRL) , Organigram (OGI) , Roku (ROKU) , Scythian Biosciences (SCCYF) and Abbott Laboratories (ABT) .

How do I buy shares of Scythian Biosciences?

Shares of SCYB stock and other Canadian stocks can be purchased through an online brokerage account. Popular online brokerages with access to the Canadian stock market include BMO InvestorLine, CIBC Investor's Edge, Desjardins Online Brokerage, HSBC InvestDirect, Laurentian Bank Discount Brokerage, National Bank Direct Brokerage, Qtrade Investor , Questrade, RBC Direct Investing, Scotia iTrade, TD Direct Investing, and Virtual Brokers. Compare Top Brokerages Here .

CVE:SCYB

Scythian Biosciences (SCYB) Stock Price, News & Analysis

→ Forget Nvidia, buy this A.I. Stock Now (From InvestorPlace) (Ad)

Buy SCYB with Qtrade

Free SCYB Stock Alerts

C$3.49

-0.22 (-5.93%)

(As of 07/25/2018)

Compare

Today's Range: C$3.46
▼
C$3.77
50-Day Range: C$3.49
▼
C$3.49
52-Week Range: C$1.01
▼
C$8.61

Volume: 703,164 shs
Average Volume: 231,491 shs
Market Capitalization: C$102.38 million

P/E Ratio: N/A
Dividend Yield: N/A
Price Target: N/A

Stock Analysis

Get Scythian Biosciences alerts:

Ad InvestorPlace

“Forget Tesla, this is Elon’s Next Big Thing”

According to Forbes, this breakthrough could define the future of AI. Most people don’t know about it… Because it was found 750 miles away from Silicon Valley.

Click here to see the details.

About Scythian Biosciences

Scythian Biosciences Corp. engages in the research and development of cannabinoid-based combination drug therapies for the treatment of concussions and traumatic brain injury. It also develops drug candidates for the treatment of gastro-intestinal inflammatory issues. The company is headquartered in Toronto, Canada.

SCYB Stock Price History

30 days | 90 days | 365 days | Advanced Chart

SCYB Stock News Headlines

February 24, 2024 | morningstar.com

Scryb Inc SCYB

September 27, 2023 | ca.finance.yahoo.com

Scryb Inc. (SCYB.CN)

April 16, 2024 | InvestorPlace (Ad)

Forget Nvidia, buy this A.I. Stock Now

Forget Nvidia, Microsoft or Google. Our tech expert and venture capitalist Luke Lango believes this is Elon Musk’s favorite A.I. stock. Why? Because this company is supplying Elon Musk with a key piece of advanced tech for his new A.I. venture.

March 18, 2023 | thestreet.com

Ventrus Biosciences (VTUS) Stock Surges Today

January 5, 2023 | finance.yahoo.com

Scale Biosciences (ScaleBio) Introduces New Disruptive Single-Cell Profiling and Analysis Solutions, Sets New Standards

June 3, 2022 | baystreet.ca

Canadian Jobs to be Presented Next Friday

See More Headlines

Receive SCYB Stock News and Ratings via Email

Sign-up to receive the latest news and ratings for Scythian Biosciences and its competitors with MarketBeat's FREE daily newsletter.

Industry, Sector and Symbol

Stock Exchange: CVE
Sector: Medical
Industry: Biotechnology
Sub-Industry: N/A
Current Symbol: CVE:SCYB
CUSIP: N/A
CIK: N/A
Web: scythianbio.com
Phone: +1-416-3669192
Fax: N/A
Employees: N/A
Year Founded: N/A

Profitability

EPS (Most Recent Fiscal Year): N/A
Trailing P/E Ratio: N/A
Forward P/E Ratio: N/A
P/E Growth: N/A
Net Income: N/A
Net Margins: N/A
Pretax Margin: N/A
Return on Equity: N/A
Return on Assets: N/A

Debt

Debt-to-Equity Ratio: N/A
Current Ratio: N/A
Quick Ratio: N/A

Sales & Book Value

Annual Sales: N/A
Price / Sales: N/A
Cash Flow: N/A
Price / Cash Flow: N/A
Book Value: N/A
Price / Book: N/A

Miscellaneous

Outstanding Shares: 29,334,000
Free Float: N/A
Market Cap: C$102.38 million
Optionable: Not Optionable
Beta: N/A

The Best High-Yield Dividend Stocks for 2024

Looking to generate income with your stock portfolio? Use these ten stocks to generate a safe and reliable source of investment income.

Get This Free Report

Key Executives

Mr. Rob Reid
CEO & Director
Mr. Jonathan James Held (Age 32)
Chief Financial Officer
Mr. Maghsoud Dariani (Age 65)
Chief Scientific Officer
Prof. Michael Barnes
Chief Medical Officer

Key Competitors

View All Competitors

SCYB Stock Analysis - Frequently Asked Questions

How have SCYB shares performed in 2024?: Scythian Biosciences' stock was trading at C$3.49 at the start of the year. Since then, SCYB stock has increased by 0.0% and is now trading at C$3.49.
View the best growth stocks for 2024 here.
What other stocks do shareholders of Scythian Biosciences own?: Based on aggregate information from My MarketBeat watchlists, some companies that other Scythian Biosciences investors own include Cross Timbers Royalty Trust (CRT), Archer-Daniels-Midland (ADM), InfraCap MLP ETF (AMZA), Alliance Resource Partners (ARLP), Brigham Minerals (MNRL), Organigram (OGI), Roku (ROKU), Scythian Biosciences (SCCYF) and Abbott Laboratories (ABT).
How do I buy shares of Scythian Biosciences?: Shares of SCYB stock and other Canadian stocks can be purchased through an online brokerage account. Popular online brokerages with access to the Canadian stock market include BMO InvestorLine, CIBC Investor's Edge, Desjardins Online Brokerage, HSBC InvestDirect, Laurentian Bank Discount Brokerage, National Bank Direct Brokerage, Qtrade Investor, Questrade, RBC Direct Investing, Scotia iTrade, TD Direct Investing, and Virtual Brokers.
Compare Top Brokerages Here.

This page (CVE:SCYB) was last updated on 4/16/2024 by MarketBeat.com Staff

From Our Partners

Get 30 Days of MarketBeat All Access Free

Best-in-Class Portfolio Monitoring
View the latest news, buy/sell ratings, SEC filings and insider transactions for your stocks. Compare your portfolio performance to leading indices and get personalized stock ideas based on your portfolio.
Stock Ideas and Recommendations
Get daily stock ideas from top-performing Wall Street analysts. Get short term trading ideas from the MarketBeat Idea Engine. View which stocks are hot on social media with MarketBeat's trending stocks report.
Advanced Stock Screeners and Research Tools
Identify stocks that meet your criteria using seven unique stock screeners. See what's happening in the market right now with MarketBeat's real-time news feed. Export data to Excel for your own analysis.

Start Your 30-Day Free Trial